United States: COVID-19 Update: Considerations For Employers Concerning COVID-19 Vaccination Programs - Paul Weiss Rifkind Wharton & Garrison
Published
Now that the Food and Drug Administration has authorized the Pfizer/BioNTech vaccine for emergency use,[1] and given the probability that one or more other COVID-19 vaccines
Full Article